Sam Altman-Backed Startup Uses AI to Accelerate Drug Clinical Trials

A $1.8 billion startup, backed by Sam Altman, is leveraging artificial intelligence to significantly speed up the process of getting drugs through clinical trials.

17 Apr, 10:30 — 17 Apr, 10:30

Post Share

Sources

Showing 1 of 1 sources

forbes2d ago

This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster - Forbes

This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster Forbes

Read full article →

PERSPECTA

PERSPECTA

Sam Altman-Backed Startup Uses AI to Accelerate Drug Clinical Trials

Sources

This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster - Forbes

Related Stories

Cavite Forecasts 'Dangerous' 42°C Heat Index

River Pollution in Nigeria Affects Rural Water Sources

Alia Bhatt's Trainer Discusses Her 'Ultra Disciplined' Routine

Pune Family Navigates Trauma One Year After Pahalgam Incident

PERSPECTA